rivastigmine has been researched along with Aging in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bloemberg, JS; de Lange, ECM; Elassaiss-Schaap, J; Saleh, MAA | 1 |
| Eap, CB; Noetzli, M | 1 |
| Chukhlovina, ML | 1 |
| Kaddoumi, A; Mohamed, LA; Qosa, H | 1 |
| Alter, J; Bogerts, B; Busse, M; Busse, S; Dobrowolny, H; Hartig, R; Mawrin, C; Steiner, J | 1 |
| Chou, YC; Cisneros-Franco, JM; de Villers-Sidani, E; Ouellet, L; Thomas, M; Voss, P | 1 |
| Duh, MS; Kahler, KH; Lefebvre, P; Mody-Patel, N; Scharre, DW; Vekeman, F | 1 |
| Brown, ME; Fahnestock, M; Francis, BM; Hajderi, E; McLaurin, J; Michalski, B; Mount, HT; Yang, J | 1 |
| Bellucci, A; Casamenti, F; Costagli, C; Pepeu, G; Scali, C; Schmidt, B | 1 |
| Jann, MW; Shirley, KL; Small, GW | 1 |
| Fukaya, H; Itanaka, K; Ohara, T; Seno, N | 1 |
| Berger, M; Braus, D; Gattaz, WF; Heuser, I; Riemann, D; Schredl, M; Weber, B | 1 |
3 review(s) available for rivastigmine and Aging
| Article | Year |
|---|---|
Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Excitatory Amino Acid Antagonists; Galantamine; Humans; Indans; Memantine; Pharmacogenetics; Phenylcarbamates; Piperidines; Receptors, N-Methyl-D-Aspartate; Rivastigmine | 2013 |
[Pathogenetic mechanisms of dementia in the older patients with Parkinson's diseases].
Topics: Aging; alpha-Synuclein; Aminoquinolines; Cholinergic Neurons; Cholinesterase Inhibitors; Dementia; Female; Galantamine; Humans; Male; Mutation; Parkinson Disease; Phenylcarbamates; Protein Kinases; Rivastigmine | 2014 |
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.
Topics: Aging; Alzheimer Disease; Biological Availability; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug Interactions; Half-Life; Humans; Indans; Intestinal Absorption; Liver; Phenylcarbamates; Piperidines; Protein Binding; Rivastigmine; Tacrine; Tissue Distribution | 2002 |
9 other study(ies) available for rivastigmine and Aging
| Article | Year |
|---|---|
Drug Distribution in Brain and Cerebrospinal Fluids in Relation to IC
Topics: Acetylcholinesterase; Aged; Aging; Alzheimer Disease; Amyloid Precursor Protein Secretases; Brain; Butyrylcholinesterase; Cholinesterase Inhibitors; Humans; Indans; Piperidines; Rivastigmine | 2022 |
Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats.
Topics: Aging; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Brain; Cholinesterase Inhibitors; Donepezil; Enzyme-Linked Immunosorbent Assay; Indans; Liver; Male; Piperidines; Rats; Rats, Sprague-Dawley; Rivastigmine | 2015 |
Expression of HLA-DR, CD80, and CD86 in Healthy Aging and Alzheimer's Disease.
Topics: Adult; Aged; Aging; Alzheimer Disease; Analysis of Variance; Antigens, CD; B7-1 Antigen; B7-2 Antigen; Cholinesterase Inhibitors; Female; HLA-DR Antigens; Humans; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Rivastigmine; Young Adult | 2015 |
Pairing Cholinergic Enhancement with Perceptual Training Promotes Recovery of Age-Related Changes in Rat Primary Auditory Cortex.
Topics: Acoustic Stimulation; Aging; Animals; Auditory Cortex; Auditory Perception; Cholinesterase Inhibitors; Discrimination Learning; Evoked Potentials, Auditory; Neuronal Plasticity; Rats; Rivastigmine | 2016 |
Use of antipsychotic drugs in patients with Alzheimer's disease treated with rivastigmine versus donepezil: a retrospective, parallel-cohort, hypothesis-generating study.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Antipsychotic Agents; Cholinesterase Inhibitors; Cohort Studies; Databases, Factual; Dementia; Donepezil; Female; Humans; Indans; Male; Phenylcarbamates; Piperidines; Retrospective Studies; Rivastigmine; Time Factors | 2010 |
Reduced tissue levels of noradrenaline are associated with behavioral phenotypes of the TgCRND8 mouse model of Alzheimer's disease.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzopyrans; Brain; Brain-Derived Neurotrophic Factor; Catecholamines; Cholinesterase Inhibitors; Desipramine; Disease Models, Animal; Imidazoles; Immobility Response, Tonic; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenylcarbamates; Recognition, Psychology; Rivastigmine | 2012 |
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
Topics: Acetylcholine; Aging; Animals; Body Weight; Brain; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Drug Administration Schedule; Hippocampus; Indans; Male; Muscarinic Antagonists; Phenylcarbamates; Piperidines; Pirenzepine; Rats; Rats, Inbred F344; Rivastigmine; Trichlorfon | 2002 |
Ameliorating effects of SDZ ENA 713 on age-associated decreases in learning performance and brain choline acetyltransferase activity in rats.
Topics: Aging; Animals; Biomarkers; Brain; Carbamates; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Drug Evaluation, Preclinical; Learning Disabilities; Male; Maze Learning; Phenylcarbamates; Rats; Rats, Inbred F344; Receptors, Muscarinic; Rivastigmine | 1997 |
The effect of rivastigmine on sleep in elderly healthy subjects.
Topics: Aged; Aging; Analysis of Variance; Carbamates; Cholinesterase Inhibitors; Female; Humans; Male; Middle Aged; Phenylcarbamates; Reference Values; Rivastigmine; Sleep, REM | 2000 |